Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 2341 AL 2355

Update on the Use of Botulinum Toxin Therapy for Focal and Task-Specific Dystonias

Lungu C, Ahmad OF.

Semin Neurol. 2016 Feb;36(1):41-6. doi: 10.1055/s-0035-1571211. Epub 2016 Feb 11.

Botulinum Toxin Treatment of Cervical Dystonia

Bledsoe IO, Comella CL.

Semin Neurol. 2016 Feb;36(1):47-53. doi: 10.1055/s-0035-1571210. Epub 2016 Feb 11.

Botulinum Toxin Treatment of Blepharospasm, Orofacial/Oromandibular Dystonia, and Hemifacial Spasm

Karp BI, Alter K.

Semin Neurol. 2016 Feb;36(1):84-91. doi: 10.1055/s-0036-1571952. Epub 2016 Feb 11.

Refractory Case of Paroxysmal Autonomic Instability With Dystonia Syndrome Secondary to Hypoxia

Kern J, Bodek D, Niazi OT, Maher J.

Chest. 2016 Feb;149(2):e39-e40. doi: 10.1016/j.chest.2015.08.003.

A Rare Cervical Dystonia Mimic in Adults: Congenital Muscular Torticollis (Fibromatosis colli), a Follow-up

Uluer MC, Bojovic B.

Front Neurol. 2016 Feb 1;7:7. doi: 10.3389/fneur.2016.00007. eCollection 2016.

Ultrasound and Electromyography Guidance for Injection of the Longus Colli With Botulinum Toxin for the Treatment of Cervical Dystonia

Allison SK, Odderson IR.

Ultrasound Q. 2016 Sep;32(3):302-6. doi: 10.1097/RUQ.0000000000000226.

Olanzapine-related repetitive focal seizures with lingual dystonia

Anzellotti F, Capasso M, Frazzini V, Onofrj M.

Epileptic Disord. 2016 Mar;18(1):83-6. doi: 10.1684/epd.2016.0805.

Genetics of movement disorders in the next-generation sequencing era

Olgiati S, Quadri M, Bonifati V.

Mov Disord. 2016 Apr;31(4):458-70. doi: 10.1002/mds.26521. Epub 2016 Feb 22.

A mixed treatment comparison to compare the efficacy and safety of botulinum toxin treatments for cervical dystonia

Han Y, Stevens AL, Dashtipour K, Hauser RA, Mari Z.

J Neurol. 2016 Apr;263(4):772-80. doi: 10.1007/s00415-016-8050-2. Epub 2016 Feb 25.

Considerations on patient-related outcomes with the use of botulinum toxins: is switching products safe?

Fraint A, Vittal P, Comella C.

Ther Clin Risk Manag. 2016 Feb 5;12:147-54. doi: 10.2147/TCRM.S99239. eCollection 2016.

A clinical trial of safety and tolerability for the selective dopamine D1 receptor antagonist ecopipam in patients with Lesch-Nyhan disease

Khasnavis T, Reiner G, Sommerfeld B, Nyhan WL, Chipkin R, Jinnah HA.

Mol Genet Metab. 2016 Apr;117(4):401-6. doi: 10.1016/j.ymgme.2016.02.005. Epub 2016 Feb 18.

Bilateral Lower Sternocleidomastoid Botulinum Toxin Injections to Address Refractory Anterocollis

Peng-Chen Z, Thompson A, Rodriguez RL.

Neurologist. 2016 Mar;21(2):30-1. doi: 10.1097/NRL.0000000000000072.

Novel mutation in SUCLA2 identified on sequencing analysis

Güngör O, Özkaya AK, Güngör G, Karaer K, Dilber C, Aydin K.

Pediatr Int. 2016 Jul;58(7):659-61. doi: 10.1111/ped.12921. Epub 2016 Mar 8.

Deep Brain Stimulation for Movement Disorders of Basal Ganglia Origin: Restoring Function or Functionality?

Wichmann T, DeLong MR.

Neurotherapeutics. 2016 Apr;13(2):264-83. doi: 10.1007/s13311-016-0426-6.

Conversion Ratio between Botox®, Dysport®, and Xeomin® in Clinical Practice

Scaglione F.

Toxins (Basel). 2016 Mar 4;8(3):65. doi: 10.3390/toxins8030065.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias